Search
for
Sort by
Research 151–180 of 1000+
- Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals
- Methotrexate in dermatology
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- 62335 Low Dose Oral Minoxidil vs Topical Minoxidil for Androgenetic Alopecia: Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- Local Injection of Triamcinolone Acetonide: A Forgotten Aetiology of Cushing’s Syndrome
- Infertility: Evaluation and Initial Management
- Medical Therapy for Female Pattern Hair Loss (FPHL)
- Female pattern alopecia: current perspectives
- Androgens in women
- Medication Repurposing: New Uses for Old Drugs
- Folliculitis decalvans managed with adalimumab: A case report
- Highlights from JAAD Reviews: August 2025—Bicalutamide for female hair loss
- Male androgenetic alopecia
- Update on Platelet-Rich Plasma and Platelet-Rich Fibrin for Dermatologic Surgery: Addressing Knowns and Unknowns
- The Effectiveness Test Of Natural Hair Growth Tonic: Avemor (Aloe Vera And Moringa Oleifera) For Thickening Hair And Anti-Licknes
- Comparison of the combination of PRP and topical minoxidil to topical minoxidil alone on androgenetic alopecia
- Testosterone in Women: Measurement and Therapeutic Use
- Two‐Year Follow‐Up of Ectodermal Dysplasia‐Syndactyly Syndrome 1 in a Palestinian Child Successfully Treated With Topical Minoxidil and Tretinoin: A Case Report
- 37-Year-Old Man With Fatigue and Erectile Dysfunction
- Mixing the Old with the New: Drug Repurposing for Immune Deficiency in the Era of Precision Medicine and Pediatric Genomics
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Controversies in off‐label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Evidence for the off-label use of tofacitinib in alopecia areata
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Off-label prescriptions: patient safety first
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Review of Promising Off-Label Use of Deucravacitinib
- Evaluation of the efficacy and safety of Narasimham hair oil in promoting hair regrowth and scalp health: A prospective open-label clinical study